News & Events
-
March 30, 2016
CDISC, C-Path and TransCelerate Announce Availability of New and Updated Standards for COPD, Virology and Diabetes
March 30, 2016 CDISC, C-Path and TransCelerate Announce Availability of New and Updated Standards for COPD, Virology and Diabetes Austin, TX – 30 March 2016 – The Clinical Data Interchange Standards Consortium (CDISC), the Critical Path Institute (C-Path) and TransCelerate BioPharma, Inc. (“TransCelerate”) today announce the open availability of new and updated CDISC...... -
November 9, 2015
CDISC and C-Path Continue CFAST Partnership with Recently Awarded FDA Grants
October 12, 2015 CDISC and C-Path Continue CFAST Partnership with Recently Awarded FDA Grants Austin, TX – 12 October 2015 – The FDA recently awarded several grants to the Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) to fund development of additional Therapeutic Area (TA) standards through their joint initiative, the...... -
July 23, 2015
CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia
July 23, 2015 CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia Austin, TX – 23 July 2015 – The Clinical Data Interchange Standards Consortium (CDISC), the Critical Path Institute (C-Path), and TransCelerate BioPharma, Inc. are pleased to announce that data standards for clinical research in the areas of Schizophrenia, Hepatitis C...... -
January 15, 2015
CFAST Launches Two New CDISC Therapeutic Area Standards For Influenza and QT Studies
January 15, 2015 CFAST Launches Two New CDISC Therapeutic Area StandardsFor Influenza and QT Studies Austin, TX – 15 January 2015 – The Clinical Data Interchange Standards Consortium (CDISC), Critical Path Institute (C-Path) and TransCelerate BioPharma Inc. (“TransCelerate”) announced today that version 1.0 of the CDISC Influenza Therapeutic Area User Guide (TAUG) and version 1.0...... -
November 19, 2014
CDISC and TransCelerate Announce Availability of New Standards for Diabetes and Cardiovascular Disease
CDISC and TransCelerate Announce Availability of New Standards for Diabetes and Cardiovascular Disease Austin, TX – 19 November 2014 – The Clinical Data Interchange Standards Consortium (CDISC) and TransCelerate BioPharma, Inc. are pleased to announce the availability of therapeutic area (TA) standards for diabetes and cardiovascular (CV) disease areas through the Coalition for Accelerating......